Norris Andrew S AS

Show results for

Unknown (30)
Metabolomics (2)
Proteomics (1)

Organisms

Alphavirus (1)
Anemia (1)
Betaherpesvirinae (1)
Brassica oleracea var. oleracea (1)
Cowpox virus (1)
Coxsackievirus (1)
Cytomegalovirus (1)
Dengue virus (1)
EFO:0001352 (1)
Filoviridae (1)
Hepatitis B virus (1)
Human alphaherpesvirus 1 (1)
Human betaherpesvirus 5 (1)
Human immunodeficiency virus (1)
Human immunodeficiency virus 1 (1)
Human immunodeficiency virus 2 (1)
Influenza A virus (1)
Influenza C virus (1)
Japanese encephalitis virus group (1)
Lyssavirus rabies (1)
Monkeypox virus (1)
Orthopoxvirus (1)
Orthopoxvirus vaccinia (1)
Rattus (1)
Staphylococcus aureus (1)
Streptococcus pneumoniae (1)
Tick-borne encephalitis virus (1)
Viruses (1)
West Nile virus (1)
cellular organisms (1)

Repository

MetaboLights (2)
pride (1)

Tissue

Cell culture (1)

Technology Type

Mass spectrometry (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Mass Spectrometry (1)

Instrument Platform

Flow injection analysis MS - negative (1)
Flow injection analysis MS - positive (1)
Liquid Chromatography MS - alternating - hilic (1)

Publication Date

2024 (1)
2023 (1)
2025 (1)

CHEBI ID

CHEBI:15919 (2)
CHEBI:30860 (2)
CHEBI:15811 (2)
CHEBI:17200 (2)
CHEBI:44215 (2)
CHEBI:16171 (2)
CHEBI:17013 (2)
CHEBI:15713 (2)
CHEBI:16264 (2)
CHEBI:17659 (2)
CHEBI:15721 (2)
CHEBI:15414 (2)
CHEBI:16680 (2)
CHEBI:17202 (2)
CHEBI:17858 (2)
CHEBI:48928 (2)
CHEBI:16695 (2)
CHEBI:17533 (2)
CHEBI:16742 (2)
CHEBI:17562 (2)
CHEBI:16750 (2)
CHEBI:16831 (2)
CHEBI:78697 (2)
CHEBI:16958 (2)
CHEBI:15741 (2)
CHEBI:16335 (2)
CHEBI:21547 (2)
CHEBI:15351 (2)
CHEBI:16108 (2)
CHEBI:14314 (2)

Metabolite Name

UTP (m+7) (1)
UTP (m+6) (1)
UTP (m+5) (1)
UTP (m+4) (1)
UTP (m+3) (1)
UTP (m+2) (1)
UTP (m+0) (1)
UMP (m+5) (1)
UMP (m+0) (1)
UDP-glucuronate (m+12) (1)
UDP-glucuronate (m+11) (1)
UDP-glucuronate (m+10) (1)
UDP-glucuronate (m+9) (1)
UDP-glucuronate (m+8) (1)
UDP-glucuronate (m+6) (1)
UDP-glucuronate (m+5) (1)
UDP-glucuronate (m+4) (1)
UDP-glucuronate (m+3) (1)
UDP-glucuronate (m+2) (1)
UDP-glucuronate (m+1) (1)
UDP-glucuronate (m+0) (1)
UDP-glucose (m+11) (1)
UDP-glucose (m+10) (1)
UDP-glucose (m+9) (1)
UDP-glucose (m+8) (1)
UDP-glucose (m+7) (1)
UDP-glucose (m+6) (1)
UDP-glucose (m+5) (1)
UDP-glucose (m+4) (1)
UDP-glucose (m+3) (1)

Release Date

2024 (4)
2017 (4)
2023 (3)
2021 (3)
2018 (3)
2015 (3)
2025 (2)
2019 (2)
2016 (2)
2022 (1)
2020 (1)
2010 (1)
2009 (1)

Lab affiliation

Department of Chemistry and Biochemistry, The Ohio State University, Columbus, OH 14 43210, USA (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Modeling Area-Level Health Rankings.

Not available

S-EPMC4600354 | biostudies-literature

Cross-linking MS supporting: Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome

The nucleocapsid N is one of four structural proteins of the coronaviruses. Its essential role in genome encapsidation makes it a critical therapeutic target for COVID-19 and related diseases. However, the inherent disorder of full-length N has hampered its structural analysis. Here, we describe a s...

ORGANISM(S): Severe acute respiratory syndrome coronavirus 2

2025-07-21 | PXD052584 | Pride

CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.

Not available

S-EPMC4433598 | biostudies-literature

AKT Inhibition in Solid Tumors With AKT1 Mutations.

Not available

S-EPMC5501365 | biostudies-literature

Protein-metabolite interactomics of carbohydrate metabolism reveal regulation of lactate dehydrogenase

Metabolic networks are interconnected and influence diverse cellular processes. The protein-metabolite interactions that mediate these networks are frequently low affinity and challenging to systematically discover. We developed mass spectrometry integrated with equilibrium dialysis for the disco...

2023-08-07 | MTBLS7237 | MetaboLights

Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells.

Not available

S-EPMC11565524 | biostudies-literature

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Not available

S-EPMC2782435 | biostudies-literature

Systematic analyses of regulatory variants in DNase I hypersensitive sites identified two novel lung cancer susceptibility loci.

Not available

S-EPMC6783905 | biostudies-literature

Tacedinaline (CI-994), a class I HDAC inhibitor, targets intrinsic tumor growth and leptomeningeal dissemination in MYC-driven medulloblastoma while making them susceptible to anti-CD47-induced macrophage phagocytosis via NF-kB-TGM2 driven tumor inflammation.

Not available